Hendrix v. Novartis Pharmaceutical Corporation
MEMORANDUM. Signed by Judge J. Frederick Motz on 5/16/14. (dass, Deputy Clerk)
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF MARYLAND
NOVARTIS PHARMACEUTICALS CORP. *
Civil No. – JFM-14-364
Defendant has filed a motion pursuant to 28 U.S.C. § 1404(a) to transfer this action to the
Central District of California.1 The motion will be granted.
Plaintiff is a resident of the Central District of California. Maryland has absolutely no
connection to the subject matter of the action. Apparently, plaintiff has brought the action in this
court because Maryland has a three year statute of limitations and his claim may be barred by
California’s two year statute of limitations.
Maryland’s statutory scheme requires application of California statute because plaintiff as
a California resident has no connections to Maryland. Md. Code, Cts & Jud. P. § 5-115(b). I
have previously upheld the constitutionality of this statute. See Helinski v. Appleton Papers, 952
F. Supp. 2d 266, 274-75 (D. Md. 1997), aff’d sub nom. Miller-Jackson v. Mead Corp., 139 F.3d
891 (4th Cir. 1998).
Plaintiff has not contested that all of the factors set forth in Section 1404(a) support
transfer of this action to the Central District of California.
Date: May 16, 2014
J. Frederick Motz
United States District Judge
For some unexplained reason, in his opposition plaintiff states that defendant seeks to transfer
the case to the United States District Court for the Southern District of Ohio.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?